(a) A drug or device is adulterated if (1) it consists in whole or in part of a filthy, putrid, or decomposed substance; (2) it has been produced, prepared, packed, or held under insanitary conditions in which it may have been contaminated with filth, or in which it may have been rendered injurious to health; […]
(a) Notwithstanding a provision or rule of law to the contrary, a health care provider authorized to prescribe an opioid overdose drug may prescribe an opioid overdose drug directly or by standing order or protocol to a person at risk of experiencing an opioid overdose or to a family member, friend, caregiver, or other person […]
A drug or device is misbranded (1) if its labeling is false or misleading in any particular; (2) if it is in package form unless it bears a label containing (A) the name and place of business of the manufacturer, packer, or distributor; and (B) an accurate statement of the quantity of the contents in […]
A drug sold on a written prescription signed by a member of the medical, dental, or veterinary profession, except a drug sold in the course of the conduct of a business of selling drugs pursuant to diagnosis by mail, is exempt from the requirements of AS 17.20.090(2) and (5) if (1) the member of the […]
(a) In preparing a drug prescription a pharmacist shall indicate on the drug container the name and strength of the drug contained in it, unless specifically directed otherwise by the prescribing physician, osteopathic physician, dentist, or veterinarian. If a drug is a mixture of pharmacologically active substances, only the name of the mixture need be […]
(a) A person may not sell, deliver, offer for sale, hold for sale, or give away a new drug unless (1) an application for it has become effective under the federal act; or (2) when not subject to the federal act unless the drug has been tested and has not been found to be unsafe […]
The application provided for in AS 17.20.110 is effective on the 60th day after the filing of it. If the commissioner finds, after notice to the applicant and providing an opportunity for a hearing, that the drug is not safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling, the commissioner […]
AS 17.20.110 does not apply to a drug (1) intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety in drugs if the drug is plainly labeled “for investigational use only”; or (2) regulated under 42 U.S.C. 262.
The commissioner is responsible for enforcing AS 17.20.080 – 17.20.135, and may delegate that authority as appropriate. This section does not limit the authority of peace officers.
In AS 17.20.080 – 17.20.135, (1) “commissioner” means the commissioner of health; (2) “department” means the Department of Health.
